Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

DemeRx is a clinical stage pharmaceutical development company advancing two lead drug candidates for medically assisted therapies for opioid addiction, Ibogaine and its active metabolite - Noribogaine. Ibogaine is an indole alkaloid from equatorial Africa. DemeRx is advancing Ibogaine for medication-assisted detoxification in controlled medically supervised inpatient settings. Noribogaine is being developed for office-based op...
DemeRx is a clinical stage pharmaceutical development company advancing two lead drug candidates for medically assisted therapies for opioid addiction, Ibogaine and its active metabolite - Noribogaine. Ibogaine is an indole alkaloid from equatorial Africa. DemeRx is advancing Ibogaine for medication-assisted detoxification in controlled medically supervised inpatient settings. Noribogaine is being developed for office-based opioid dependent withdrawal treatment and for detoxification of incarcerated addicts.

List your booth number for exhibitions, ask us